These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4135044

  • 1. [Intrahepatic cholestasis following ovosiston].
    Kraatz G, Linke A.
    Z Arztl Fortbild (Jena); 1973 Dec 01; 67(23):1194-6. PubMed ID: 4135044
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Jaundice in intrahepatic cholestasis after ovulation inhibitors].
    Piesbergen H.
    Med Welt; 1968 Feb 17; 9():451-3. PubMed ID: 4181421
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
    Ebeling K, Kühndel K, Rothe K, Canzler E.
    Z Arztl Fortbild (Jena); 1971 Dec 15; 65(24):1275-8. PubMed ID: 4111418
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Menstruation disorders due to Ovosiston medication].
    Kühndel K, Ebeling K, Rothe K.
    Dtsch Gesundheitsw; 1971 Jan 14; 26(3):109-13. PubMed ID: 4106361
    [No Abstract] [Full Text] [Related]

  • 8. Primary dysmenorrhea: combination vs sequential therapy.
    Buttram VC, Kaufman RH.
    Tex Med; 1969 Aug 14; 65(8):52-5. PubMed ID: 4185963
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cholestatic icterus after intake of ovulation inhibitors].
    Pansold E, Fischer I, Pfeifer K.
    Dtsch Gesundheitsw; 1974 Mar 02; 29(10):470-5. PubMed ID: 4142434
    [Abstract] [Full Text] [Related]

  • 11. [Sequenz-Ovosiston as a contraceptive agent].
    Zwahr C.
    Zentralbl Gynakol; 1972 Dec 09; 94(49):1722-5. PubMed ID: 4119508
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
    Müller R, Kempf HJ, Eckert L.
    Zentralbl Gynakol; 1968 Nov 16; 90(46):1545-55. PubMed ID: 4179333
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
    Iizuka R, Koi H, Saga M, Shibuya T, Hongo K.
    Sanfujinka No Jissai; 1970 Nov 16; 19(3):322-30. PubMed ID: 4192774
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
    Heller H.
    Dtsch Gesundheitsw; 1972 Jun 01; 27(22):1035-8. PubMed ID: 4114489
    [No Abstract] [Full Text] [Related]

  • 20. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen.
    Roland M, Clyman M, Decker A, Ober WB.
    Pac Med Surg; 1966 Jun 01; 74(3):135-8. PubMed ID: 4160710
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.